Zinzino AB Class B ( (ZNZNF) ) has released its Q3 earnings. Here is a breakdown of the information Zinzino AB Class B presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zinzino AB, a Scandinavian direct sales company, specializes in test-based, personalized dietary supplements and scientific skincare, with a presence in over 100 markets worldwide. The company recently reported a robust financial performance for Q3 2025, showcasing significant growth and profitability. Total revenue for the quarter increased by 47% year-over-year to SEK 784.1 million, with a gross profit margin of 35.4%. The EBITDA margin improved to 14.0%, and net earnings rose to SEK 89.4 million. Strategic acquisitions, including Bodē Pro and Truvy, have bolstered Zinzino’s distribution capabilities in North America, Latin America, and Asia, contributing to this growth. The company also launched a new Gut Health Test, which has seen strong sales, enhancing brand visibility and customer engagement. Looking ahead, Zinzino aims to maintain its growth trajectory by expanding its market presence and product offerings, leveraging its technological platform, and pursuing strategic acquisitions.